tirzepatide shortage fda reconsidering its decision to take off its drug list What is the latest update

That makes the first three months a checkpoint rather than a verdict, and any change to the plan belongs with the prescriber

This product is intended for pre-clinical laboratory research only and is not formulated for human use

Sixteen state Medicaid programs the federal and state initiative that provides free health insurance to low-income people covered the drugs for obesity in October 2025 (though, notably, most states cover GLP-1 drugs for diabetes)

Compounded tirzepatide is prepared by licensed 503A pharmacies and shipped directly to you, serving all 50 states with no insurance requirement or membership fees

However, when they stopped taking semaglutide, many patients began to regain weight

Chen K, Yan J, Suo Y, Li J, Wang Q, Lv B